US FDA’s Tidmarsh Takes On Surrogate Endpoints, Maybe Old Business Partner, On LinkedIn

 
• By Sarah Karlin-Smith
  
picture of phone with Linkedin website over keyboard
Tidmarsh posted, but later deleted, a LinkedIn message on surrogate endpoints. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership